- To investigate the association of eGFR on risk of contracting COVID-19 and subsequent adverse outcomes.
- Rates of hospital-diagnosed COVID-19 were compared across strata of eGFR based on conditional logistic regression using a nested case-control framework with 1:4 matching of patients diagnosed with COVID-19 with controls from the Danish general population on age, gender, diabetes, and hypertension.
- Cohort Study
- eGFR was inversely associated with rate of hospital-diagnosed COVID-19
- Renal insufficiency was associated with progressive increase in both rate of hospital-diagnosed COVID-19 and subsequent risk of adverse outcomes. Results underscore a possible vulnerability associated with impaired renal function in relation to COVID-19.

Emory University

- CKD, also known as chronic renal disease,  is a chronic, non-communicable, irreversible condition where kidney function gradually declines over time.
- However, CKD progression can be slowed down dramatically or even stopped.
- The earlier stages of CKD are usually asymptomatic.
- Diabetes and high blood pressure cause almost two-thirds of CKD cases.
- Source: https://www.kidney.org/atoz/content/about-chronic-kidney-disease

Chronic Kidney Disease

Carlson, N., Nelveg-Kristensen, K. E., Freese Ballegaard, E., Feldt-Rasmussen, B., Hornum, M., Kamper, A. L., Gislason, G., & Torp-Pedersen, C. (2021). Increased vulnerability to Covid-19 in chronic kidney disease. Journal of internal medicine, 10.1111/joim.13239. Advance online publication. https://doi.org/10.1111/joim.13239

Learn Before

Related